Manchenko, Maria A
For the study, researchers collected information from 411 participants taking GLP-1 medications on potential changes to their sense of taste, appetites, satiety, and food cravings after starting treatment
Tirzepatide is somewhat better tolerated (~29% nausea in SURMOUNT-1)
Reports by themselves are not an indicator of a drugs safety profile
Considering "GLP-1 weight loss Mountain Home, Arkansas"
Medications with narrow therapeutic indices Drugs where small changes in blood levels can cause significant problems, warfarin, digoxin, lithium, certain anti-epileptic medications, deserve careful monitoring when combined with tirzepatide